Observational Study
Copyright ©The Author(s) 2018.
World J Gastroenterol. May 14, 2018; 24(18): 2036-2046
Published online May 14, 2018. doi: 10.3748/wjg.v24.i18.2036
Table 1 Demographics, Tanner stage, disease location, and medications
Itemn (%)
Race
Asian12 (14.6)
East Asian6
South Asian6
Black/African American1 (1.2)
Other4 (4.9)
White65 (79.3)
Ethnicity
Hispanic or Latino7 (8.5)
Not Hispanic or Latino75 (91.5)
Tanner stage
18 (9.8)
215 (18.3)
316 (19.5)
424 (29.3)
519 (23.2)
Disease location
Esophagus or stomach9 (11)
Small bowel, no colon12 (14.6)
Colon, no small bowel17 (20.7)
Small bowel and colon53 (64.6)
Perianal disease49 (59.8)
Medication
Adalimumab4 (4.9)
5-Aminosalicylates50 (61.0)
Antibiotics14 (17.1)
Azathioprine/6-Mercaptopurine44 (53.7)
Infliximab20 (24.4)
Methotrexate7 (8.5)
Steroids ever55 (67.1)